• Je něco špatně v tomto záznamu ?

Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design

CL. Gardner, J. Hritz, C. Sun, DL. Vanlandingham, TY. Song, E. Ghedin, S. Higgs, WB. Klimstra, KD. Ryman,

. 2014 ; 8 (2) : e2719.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008245

Mosquito-borne chikungunya virus (CHIKV) is a positive-sense, single-stranded RNA virus from the genus Alphavirus, family Togaviridae, which causes fever, rash and severe persistent polyarthralgia in humans. Since there are currently no FDA licensed vaccines or antiviral therapies for CHIKV, the development of vaccine candidates is of critical importance. Historically, live-attenuated vaccines (LAVs) for protection against arthropod-borne viruses have been created by blind cell culture passage leading to attenuation of disease, while maintaining immunogenicity. Attenuation may occur via multiple mechanisms. However, all examined arbovirus LAVs have in common the acquisition of positively charged amino acid substitutions in cell-surface attachment proteins that render virus infection partially dependent upon heparan sulfate (HS), a ubiquitously expressed sulfated polysaccharide, and appear to attenuate by retarding dissemination of virus particles in vivo. We previously reported that, like other wild-type Old World alphaviruses, CHIKV strain, La Réunion, (CHIKV-LR), does not depend upon HS for infectivity. To deliberately identify CHIKV attachment protein mutations that could be combined with other attenuating processes in a LAV candidate, we passaged CHIKV-LR on evolutionarily divergent cell-types. A panel of single amino acid substitutions was identified in the E2 glycoprotein of passaged virus populations that were predicted to increase electrostatic potential. Each of these substitutions was made in the CHIKV-LR cDNA clone and comparisons of the mutant viruses revealed surface exposure of the mutated residue on the spike and sensitivity to competition with the HS analog, heparin, to be primary correlates of attenuation in vivo. Furthermore, we have identified a mutation at E2 position 79 as a promising candidate for inclusion in a CHIKV LAV.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008245
003      
CZ-PrNML
005      
20150331120147.0
007      
ta
008      
150306s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pntd.0002719 $2 doi
035    __
$a (PubMed)24587470
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gardner, Christina L $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Microbiology & Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
245    10
$a Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design / $c CL. Gardner, J. Hritz, C. Sun, DL. Vanlandingham, TY. Song, E. Ghedin, S. Higgs, WB. Klimstra, KD. Ryman,
520    9_
$a Mosquito-borne chikungunya virus (CHIKV) is a positive-sense, single-stranded RNA virus from the genus Alphavirus, family Togaviridae, which causes fever, rash and severe persistent polyarthralgia in humans. Since there are currently no FDA licensed vaccines or antiviral therapies for CHIKV, the development of vaccine candidates is of critical importance. Historically, live-attenuated vaccines (LAVs) for protection against arthropod-borne viruses have been created by blind cell culture passage leading to attenuation of disease, while maintaining immunogenicity. Attenuation may occur via multiple mechanisms. However, all examined arbovirus LAVs have in common the acquisition of positively charged amino acid substitutions in cell-surface attachment proteins that render virus infection partially dependent upon heparan sulfate (HS), a ubiquitously expressed sulfated polysaccharide, and appear to attenuate by retarding dissemination of virus particles in vivo. We previously reported that, like other wild-type Old World alphaviruses, CHIKV strain, La Réunion, (CHIKV-LR), does not depend upon HS for infectivity. To deliberately identify CHIKV attachment protein mutations that could be combined with other attenuating processes in a LAV candidate, we passaged CHIKV-LR on evolutionarily divergent cell-types. A panel of single amino acid substitutions was identified in the E2 glycoprotein of passaged virus populations that were predicted to increase electrostatic potential. Each of these substitutions was made in the CHIKV-LR cDNA clone and comparisons of the mutant viruses revealed surface exposure of the mutated residue on the spike and sensitivity to competition with the HS analog, heparin, to be primary correlates of attenuation in vivo. Furthermore, we have identified a mutation at E2 position 79 as a promising candidate for inclusion in a CHIKV LAV.
650    _2
$a biologická adaptace $x účinky léků $x genetika $7 D000220
650    _2
$a substituce aminokyselin $x genetika $7 D019943
650    _2
$a zvířata $7 D000818
650    _2
$a neutralizující protilátky $x imunologie $7 D057134
650    12
$a virus chikungunya $x účinky léků $x genetika $x imunologie $x patogenita $7 D002646
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a heparitinsulfát $x farmakologie $7 D006497
650    _2
$a myši $7 D051379
650    _2
$a molekulární modely $7 D008958
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a statická elektřina $7 D055672
650    _2
$a atenuované vakcíny $x genetika $x imunologie $7 D014613
650    _2
$a proteiny virového obalu $x genetika $7 D014759
650    _2
$a virové vakcíny $x genetika $x imunologie $7 D014765
650    _2
$a virulence $x genetika $7 D014774
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Hritz, Jozef $u CEITEC, Masaryk University, Brno, Czech Republic.
700    1_
$a Sun, Chengqun $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Microbiology & Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
700    1_
$a Vanlandingham, Dana L $u Department of Diagnostic Medicine & Pathobiology, Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, United States of America.
700    1_
$a Song, Timothy Y $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
700    1_
$a Ghedin, Elodie $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
700    1_
$a Higgs, Stephen $u Department of Diagnostic Medicine & Pathobiology, Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, United States of America.
700    1_
$a Klimstra, William B $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Microbiology & Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
700    1_
$a Ryman, Kate D $u Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Department of Microbiology & Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
773    0_
$w MED00165375 $t PLoS neglected tropical diseases $x 1935-2735 $g Roč. 8, č. 2 (2014), s. e2719
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24587470 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150331120416 $b ABA008
999    __
$a ok $b bmc $g 1065518 $s 891045
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 8 $c 2 $d e2719 $i 1935-2735 $m PLoS neglected tropical diseases $n PLoS negl. trop. dis. $x MED00165375
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...